In order to address the role of autotaxin in the obesity‐related cardiomyopathy, we next utilized PF‐8380, a specific inhibitor of autotaxin,24 to explore the cardiac changes after suppression of autotaxin activity. The gene discussed is ENPP2; the disease is obesity disorder.